Evidence Hub

Generalized morphea after COVID‐19 vaccines: a case series

G. Paolino, C. Campochiaro, M. D. Di Nicola, S. Mercuri, N. Rizzo, L. Dagna, F. Rongioletti, G. de Luca

Journal of the European Academy of Dermatology and Venereology, 2022

16 citations

Abstract

Maskne prevalence and associated factors in Irish healthcare workers during the COVID-19 pandemic. J Eur Acad Dermatol Venereol 2022; 36: e506–e508. https://doi.org/10.1111/jdv.18054 3 Damiani G, Gironi LC, Grada A et al. COVID-19 related masks increase severity of both acne (maskne) and rosacea (mask rosacea): multi-center, real-life, telemedical, and observational prospective study. Dermatol Ther 2021; 34: e14848. 4 Villani A, Annunziata MC, Megna M, Scalvenzi M, Fabbrocini G. Longterm results of teledermatology for acne patients during COVID-19 pandemic. J Cosmet Dermatol 2022; 21, 1356–1357. 5 Villani A, Annunziata MC, Abategiovanni L, Fabbrocini G. Teledermatology for acne patients: how to reduce face-to-face visits during COVID-19 pandemic. J Cosmet Dermatol 2020; 19: 1828. 6 Giacalone S, Minuti A, Spigariolo CB, Passoni E, Nazzaro G. Facial dermatoses in the general population due to wearing of personal protective masks during the COVID-19 pandemic: first observations after lockdown. Clin Exp Dermatol 2020; 46: 368–369.

How strong is the evidence?

Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free